 |
 |
|
 |
| 「寄付講座 臨床遺伝学研究室」の研究業績のデータです。 |
|
[ 論 文 ]
| 1. |
Tsukimura T., Shiga T., Saito K., Ogawa Y., Sakuraba H., Togawa T.: Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice? Mol. Genet. Metab. Reports, 28：100773, 2021.
|
| 2. |
Nagata A., Nasu M., Kaida Y., Nakayama Y., Kurokawa Y., Nakamura N., Shibata R., Hazama T., Tsukimura T., Togawa T., Saito S., Sakuraba H., Fukami K.: Screening of Fabry disease in patients with chronic kidney disease in Japan. Nephrol. Dial. Transplant. (NDT), 37: 115-125, 2021. doi: 10.1093/ndt/gfaa324.
|
| 3. |
Shiga T., Tsukimura T., Namai Y., Togawa T., Sakuraba H.: Comparative urinary globotriaosylceramide analysis by thin-layer chromatography-immunostaining and liquid chromatography-tandem mass spectrometry in patients with Fabry disease. Mol. Genet. Metab. Reports, 29: 100804, 2021. doi.org/10.1016/j.ymgmr.2021.100804
|
| 4. |
Kami D., Suzuki Y., Yamanami M., Tsukimura T., Togawa T., Sakuraba H., Gojo S.: Genetically modified cell transplantation through microencapsulated spheroids with scaffolds to treat Fabry disease. Cell Transplant., 30: 9636897211060269, 2021.
|
|
|
 |
|
|
|
|
|
|
|
|
